Process for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprol

  • US 6,861,076 B2
  • Filed: 01/16/2004
  • Issued: 03/01/2005
  • Est. Priority Date: 11/10/1997
  • Status: Expired due to Term
First Claim
Patent Images

1. A method for treating acute promyelocytic leukemia, comprising determining a dosage amount of arsenic trioxide for the treatment of a patient diagnosed with acute promyelocytic leukemia, based on the weight of the patient and a dose of 0.15 mg/kg of patient body weight, and administering arsenic trioxide in said dosage amount to said patient, wherein said arsenic trioxide is administered for a maximum of 60 days or until bone marrow remission, wherein said administering constitutes a first administration.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×